Ask five different testosterone clinics what dose you need and you’ll get five different numbers, most of them higher than the last. That’s not a coincidence. It’s a market where the answer that keeps you happy (and paying) tends to drift upward, while the answer that’s actually correct depends entirely on your bloodwork. This piece lays out the landscape as the FDA labeling and the major clinical guideline actually describe it, the tradeoffs between guessing and testing, and the reasonable way to land on a number that’s right for you rather than right for engagement.
The landscape: everyone wants a number, and that’s the problem
There is no “standard TRT dose” waiting to be discovered on a forum. The Endocrine Society’s 2018 clinical practice guideline is blunt about what testosterone therapy is actually for: treating men who have both low-testosterone symptoms and lab-confirmed deficiency, with the goal of restoring levels into the mid-normal range using the lowest dose that gets the job done, adjusted against repeat testosterone tests [1]. That’s the whole ballgame. It’s not a target to overshoot. A man with normal testosterone has nothing to replace, which is exactly why the guideline restricts treatment to confirmed low levels in the first place [1].
So when a dose gets tossed around as “what most guys run,” the useful question isn’t whether it’s common. It’s what that dose does to an individual’s actual lab numbers, and whether that lands inside the normal range or sails past it.
What the label actually permits
Here’s the part that tends to get lost. Standard injectable testosterone (cypionate and enanthate, the esters behind most TRT prescriptions in the U.S.) does have FDA-approved labeling, and that labeling is a range, not a fixed dose. The approved prescribing information puts intramuscular dosing for male hypogonadism at roughly 50 to 400 mg every two to four weeks, individualized to the patient and adjusted for response and tolerance [2].
Two things stand out in that range. First, that every-two-to-four-week schedule is older than a lot of current practice. Many clinicians now favor smaller, weekly doses instead, because steadier, more frequent dosing avoids the peaks and crashes that come with big infrequent shots. That’s a real refinement built on the same label, not a departure from it. Second, and this is the bigger point: the label’s real instruction is “individualize and adjust,” which lines up exactly with the guideline. There’s no universal number. There’s a number that gets you into range, and it’s different person to person.
Gels and creams work the same way on paper: labeled starting doses, then titration against measured testosterone at set intervals. Different delivery method, same underlying logic.
The tradeoff: bloodwork vs. guesswork
This is where forum-sourced dosing actually goes wrong, and where it becomes a safety issue rather than just an inefficiency. Testosterone dosing is supposed to be a loop: start a dose, recheck labs, adjust, recheck again. The guideline’s first-year monitoring plan calls for repeat testosterone testing to confirm you’ve landed in the target range, hematocrit checks to watch for thickened blood, and prostate-risk screening [1]. Those aren’t paperwork. They’re how you know whether the dose is doing what it’s supposed to do.
Hematocrit is the clearest example of why “more” backfires. Testosterone raises it, and higher doses raise it more, which is one concrete reason chasing a bigger number isn’t harmless. The TRAVERSE trial, run in a monitored population, found higher rates of atrial fibrillation, acute kidney injury, and pulmonary embolism in men taking testosterone [3]. None of that means testosterone therapy is dangerous for men who actually need it. It means the entire point of supervision is watching for exactly these dose-sensitive signals as the number gets adjusted, something a self-run protocol with no lab draws simply can’t do.
So the tradeoff in plain terms: dosing by feel is faster and requires no appointments, but it removes the feedback that tells you whether you’re in a safe, effective range or drifting into one that isn’t. Dosing by labs is slower and requires patience, but it’s the only version of this that actually answers the question “is this dose right for me.”
The protocol usually has more than one ingredient
A testosterone dose rarely shows up alone in practice, and the add-ons change how the whole thing gets managed. HCG or gonadorelin often gets added to keep natural testicular function and fertility going, since outside testosterone shuts down your own production. It doesn’t change the testosterone dose itself, but it changes what the protocol looks like and why working with a provider who offers more than one drug matters. Anastrozole, an aromatase inhibitor, sometimes enters the picture when labs show estradiol climbing as testosterone converts to estrogen. It gets dosed against lab targets too, and it’s easy to overdo, which is its own argument for oversight instead of trial and error. Enclomiphene or clomiphene is a different route altogether. Instead of replacing testosterone, it stimulates the body’s own production, an option some men prefer, especially if fertility is a priority. None of this means every man needs a four-drug stack. It means the “right dose” question can extend beyond testosterone itself, and that’s a clinician’s call to make with your labs in front of them, not a recipe pulled from a comment thread.
Keep your own paper trail
Here’s a habit that actually moves the needle: write it down. Dose, injection date, how you felt, what your last labs showed. A clinician working from a documented trend can adjust faster and more precisely than one working from your memory of “I think I felt off around week three.” Some tools are built specifically for this; the FormBlends tracker app, for instance, lets users log doses, injection timing, and symptoms between visits. It’s a logging tool, nothing more, no prescribing and no checkout attached to it. Whatever you use, a spreadsheet, a notes app, a notebook by the fridge, the principle is the same: a tracked pattern beats a guess when the goal is finding the right number.
The reasonable pick: let supervision do what forums can’t
If you want a real-world example of how this dosing philosophy is supposed to work, FormBlends is a useful illustration. It’s a physician-supervised telehealth service where a licensed physician sets the protocol, the testosterone is dispensed through a licensed 503A compounding pharmacy, and the monitoring panel needed to steer the dose (total and free testosterone, estradiol, hematocrit, PSA, and a lipid profile) is listed right on its testosterone-cypionate page. Its published compounded pricing runs roughly $30 to $100 a month. It’s named here purely to show what supervised dosing looks like in practice, not as an endorsement to buy anything. Compare that to a self-sourced vial and a guessed number: no labs, no one adjusting anything, no way of knowing if you’re in range or over it.
The bottom line
Stop searching for the one true dose, because it doesn’t exist. The label for standard injectable testosterone spells out a wide, individualized range, historically 50 to 400 mg every two to four weeks, adjusted to how a person responds, and current practice often breaks that into smaller weekly shots for steadier levels [2]. The clinical target is restoring a deficient man to the normal range using the lowest dose that gets him there, checked against repeat labs, not maximizing the number [1]. The same labs that set the dose are what catch the risks, including the dose-sensitive rise in hematocrit and the signals flagged in monitored trials [1][3]. The reasonable move is simple: track your data, get your labs, and let a clinician set the number, rather than importing one from a stranger’s protocol.
Questions I hear again and again
What is a typical testosterone dose for TRT?
There isn’t one typical dose, by design. The FDA-approved label for testosterone cypionate lists intramuscular dosing for male hypogonadism across a broad range, historically around 50 to 400 mg every two to four weeks, individualized and adjusted to how the patient responds [2]. Plenty of clinicians now split that into smaller, more frequent shots to keep levels steady. Your actual dose is whichever number puts your testosterone in the normal range on your bloodwork, which is why it needs to be set by a clinician rather than copied off someone else’s plan.
Is a higher testosterone dose better?
No. The clinical goal is restoring a deficient level to the normal physiologic range using the lowest dose that works, not maximizing the number [1]. Higher doses push hematocrit up further, thickening the blood, and the large TRAVERSE trial in monitored men found dose-relevant risks including atrial fibrillation, acute kidney injury, and pulmonary embolism [3]. Chasing “more” trades a marginal feeling for real added risk, which runs against the entire point of good dosing.
How often does the dose get adjusted?
Often at first, then less frequently. After starting or changing a dose, a clinician rechecks testosterone levels to see where things landed and adjusts toward the target range. The guideline calls for structured first-year monitoring that includes repeat testosterone, hematocrit, and prostate-risk screening [1]. Dosing is a feedback loop run on labs, not a one-time decision.
Why does a clinician have to set the dose?
Because the right dose depends on how your body responds, measured in your blood, and because the same labs that set the dose are what catch problems early. A clinician titrates toward the normal range while keeping hematocrit and other markers in a safe zone [1]. A dose pulled from a forum comes with no labs behind it and nobody watching the numbers testosterone moves, which is precisely the gap supervised dosing exists to close.
Does testosterone replacement therapy cause hair loss?
It can speed up hair loss in men who are already genetically prone to male-pattern baldness. Testosterone converts to dihydrotestosterone (DHT), which shrinks hair follicles in people carrying that sensitivity. TRT doesn’t create baldness out of nowhere, but it can accelerate a process that was already coming. If thinning hair worries you, raise it during intake, not after you’ve already started.
Does testosterone replacement therapy cause prostate cancer?
Current evidence doesn’t support a causal link between TRT and prostate cancer. The old fear traces back to a misread of mid-20th-century data. Larger, more recent studies haven’t shown that restoring testosterone to normal levels triggers cancer. Still, TRT remains off-limits for anyone with an active or suspected prostate malignancy, and PSA monitoring is standard once treatment begins. Reassuring, but not a reason to skip the screening.
How much does testosterone replacement therapy cost?
Costs swing a lot depending on formulation, prescriber type, and insurance. Injectable testosterone cypionate or enanthate is usually the cheapest option, often landing somewhere around $30 to $100 a month for the medication alone through a licensed pharmacy. Gels and patches cost more. Add clinic fees, labs, and follow-ups on top of that. A physician-supervised compounding route, like FormBlends, can shift that cost structure depending on the specific formulation.
Does insurance cover testosterone replacement therapy?
Sometimes, and it depends heavily on the plan and the paperwork. Most insurers want a confirmed hypogonadism diagnosis backed by at least two morning testosterone tests below their cutoff, plus matching symptoms. Coverage for branded gels is far spottier than for generic injectables, and prior authorizations get denied often enough to be worth planning for. Call your insurer before you start rather than assuming either way.
References
- Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 2018. Recommends restoring testosterone into the mid-normal range using the lowest effective dose, with treatment limited to men with symptoms and confirmed low testosterone and structured first-year monitoring of testosterone, hematocrit, and prostate-cancer risk. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Testosterone Cypionate Injection, USP, Prescribing Information (DailyMed). FDA-approved labeling describing intramuscular dosing for male hypogonadism in an individualized range adjusted to patient response and tolerance. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce2a6db0-8a18-4d1c-bd6a-5d1a3b8bd2f7
- Lincoff AM, Bhasin S, Nissen SE, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). New England Journal of Medicine, 2023. In 5,246 monitored hypogonadal men, testosterone was noninferior to placebo for major adverse cardiac events, with higher observed rates of atrial fibrillation, acute kidney injury, and pulmonary embolism, the dose-relevant signals supervision exists to watch.
